Because PANX1 is upregulated in most other cancer types in which it has been reported, including melanoma, breast cancer and leukemia (Laird & Penuela, 2021), it seems more likely that PANX1 is increased in cSCC compared to normal tissue. This evidence concerns the gene PANX1 and breast carcinoma.